지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.1
- 수록면
- 7 - 11 (5page)
이용수
초록· 키워드
오류제보하기
Transarterial chemoembolization (TACE) is recommended as the first line treatment option for the patients with Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC), however, treatment strategy and evaluation of effects after TACE has not been fully established. Recently, sub-stage of BCLC stage B has been proposed and validated, but it should be validated including a large number of the patients and its refinement should be discussed. We have validated the sub-stage of BCLC stage B (B1-B4) by comparing overall survival after TACE, and there was no statistically significant difference in overall survival after TACE between B1 and B2. After excluding the patients with Child-Pugh point 7 from B1, the overall survival was significantly better than that of B2. Therefore, up-to-seven criteria is shown to be a reliable tool for the treatment strategy in the patients with intermediate stage of HCC. Refinement of sub-stage of BCLC stage B has been proposed by some other institutes, and it is important to establish novel treatment strategy for the patients with BCLC stage B after TACE to improve the prognosis of the patients after TACE, and to define the best timing for conversion to sorafenib or liver transplantation should be discussed.
목차
등록된 정보가 없습니다.
참고문헌 (18)
참고문헌 신청
Bruix J / 2011 / American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update / Hepatology 53:1020~1022
Jordi Bruix / 2016 / Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma / Gastroenterology 150(4):835~853
Kudo M / 2011 / Management of hepatocellular carcinoma in Japan : consensus-based clinical practice guidelines proposed by Japan Society of Hepatology(JSH)2010 updated version / Dig Dis 29:339~364
한국 간 암 스터디그룹 / 2015 / 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma / Gut and Liver 9(3):267~317
Kadalayil L / 2013 / A simple prognostic scoring system for patients receiving transarterial embolization for hepatocellular cancer / Ann Oncol 24:2565~2570
Jordi Bruix / 2016 / Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma / Gastroenterology 150(4):835~853
Kudo M / 2011 / Management of hepatocellular carcinoma in Japan : consensus-based clinical practice guidelines proposed by Japan Society of Hepatology(JSH)2010 updated version / Dig Dis 29:339~364
한국 간 암 스터디그룹 / 2015 / 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma / Gut and Liver 9(3):267~317
Kadalayil L / 2013 / A simple prognostic scoring system for patients receiving transarterial embolization for hepatocellular cancer / Ann Oncol 24:2565~2570
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
Clinical and Molecular Hepatology
2021 .01
-
The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Clinical and Molecular Hepatology
2017 .01
-
Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
Journal of Liver Cancer
2020 .01
-
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
Journal of Liver Cancer
2023 .03
-
Transarterial chemoembolization versus resection for the intermediate stage hepatocellular carcinoma
Clinical and Molecular Hepatology
2016 .01
-
Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
Cancer Research and Treatment
2019 .01
-
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Clinical and Molecular Hepatology
2020 .01
-
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
Journal of Liver Cancer
2024 .09
-
Rare Case of Pyogenic Brain Abscess after Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma: Case Report and Literature Review
Journal of Liver Cancer
2021 .01
-
Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation
Annals of Surgical Treatment and Research
2018 .08
-
Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma
Yonsei Medical Journal
2017 .07
-
Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
Journal of Liver Cancer
2020 .01
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Clinical and Molecular Hepatology
2023 .04
-
Efficacy of Transarterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Barcelona Clinic Liver Cancer 중간 병기 간세포암종 환자의 병기세분화
Journal of Liver Cancer
2016 .01
-
Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report
International Journal of Gastrointestinal Intervention
2021 .01
-
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
Cancer Research and Treatment
2018 .01
-
Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Current role of systemic therapy in transarterial chemotherapy-refractory hepatocellular carcinoma patients
International Journal of Gastrointestinal Intervention
2021 .10
-
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
International Journal of Gastrointestinal Intervention
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0